Active Not RecruitingNCT05032105
Focused ultrasound and anxiety in people with treatment-resistant epilepsy
About this title
Read the official source — NCT05032105This study assesses anxiety symptoms.
Device studyAges 18–65United States
Understand this study
What is this study about?
This study assesses anxiety symptoms.
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- ColumbusSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 4, 2024
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 2
- Sponsor
- Ohio State University
- Sponsor type
- University
- Study type
- Device
- Intervention type
- Device
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05032105
- Official title
Show the full official title
.An Open-label Clinical Trial Evaluating the ExAblate Model 4000 Type-1 Focused Ultrasound Unilateral Thalamotomy for Patients With Treatment-refractory Focal Onset Epilepsy and Comorbid Anxiety.
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Columbus
Interested in joining this study?
Questions about this study
What is this study about?
This study assesses anxiety symptoms.
Who is behind this study?
The study sponsor is Ohio State University, a university.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
